FDA Inspection 1251559 — Sabine S. Hazan, M.D.

Sabine S. Hazan, M.D. — FEI 3016661283

The FDA completed an inspection of Sabine S. Hazan, M.D. on September 26, 2024 in Ventura, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 26, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Ventura, CA (United States)

Additional Details

Clinical Investigator (CI)